NRC Health financials
$21.05+4.94%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $137.4M | $143.1M | $148.6M | $151.6M | $148.0M | $133.8M | $128.0M | $119.7M |
| Gross profit | $85.0M | $86.1M | $92.6M | $151.6M | $148.0M | $133.8M | $128.0M | $119.7M |
| Gross margin | 61.9% | 60.2% | 62.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $22.6M | $35.2M | $40.0M | $46.5M | $50.3M | $42.7M | $43.0M | $35.3M |
| Net income | $11.3M | $24.8M | $31.0M | $31.8M | $37.5M | $37.3M | $32.4M | $25.4M |
| Net margin | 8.2% | 17.3% | 20.8% | 21.0% | 25.3% | 27.8% | 25.3% | 21.2% |
| Diluted EPS | $0.50 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | $1.04 |
| EBITDA | $30.2M | $41.2M | $45.9M | $51.8M | $56.6M | $50.2M | $48.6M | $40.7M |
| Operating cash flow | $26.4M | $34.6M | $38.1M | $36.3M | $46.3M | $40.6M | $40.9M | $39.8M |
| Free cash flow | $15.7M | $19.2M | $22.3M | $26.4M | $40.8M | $36.7M | $36.3M | $33.9M |
| Diluted shares | 22.4M | 23.7M | 24.7M | 25.1M | 25.6M | 25.7M | 25.7M | 24.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.1M | $4.2M | $6.7M | $25.0M | $54.4M | $34.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $79.0M | $62.7M | $36.7M | $22.2M | $26.5M | $30.6M |
| Total assets | $134.9M | $132.5M | $122.4M | $130.5M | $157.5M | $133.4M |
| Total liabilities | $120.9M | $101.3M | $73.5M | $58.4M | $72.2M | $69.1M |
| Shareholders' equity | $14.0M | $31.3M | $49.0M | $72.0M | $85.3M | $64.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology